{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:40:46Z","timestamp":1790516446782,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T00:00:00Z","timestamp":1542931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["1808085MH246"],"award-info":[{"award-number":["1808085MH246"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.biopha.2018.08.146","type":"journal-article","created":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T20:35:56Z","timestamp":1537562156000},"page":"741-751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Downregulation of EB virus miR-BART4 inhibits proliferation and aggressiveness while promoting radiosensitivity of nasopharyngeal carcinoma"],"prefix":"10.1016","volume":"108","author":[{"given":"Qibing","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"July (3)","key":"10.1016\/j.biopha.2018.08.146_bib0005","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.soc.2015.03.008","article-title":"Nasopharyngeal carcinoma","volume":"24","author":"Kamran","year":"2015","journal-title":"Surg. Oncol. Clin. N. Am."},{"issue":"October (10)","key":"10.1016\/j.biopha.2018.08.146_bib0010","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1158\/1055-9965.EPI-06-0353","article-title":"The enigmatic epidemiology of nasopharyngeal carcinoma","volume":"15","author":"Chang","year":"2006","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"April (2)","key":"10.1016\/j.biopha.2018.08.146_bib0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.semcancer.2012.01.009","article-title":"Non-viral environmental risk factors for nasopharyngeal carcinoma: a systematic review","volume":"22","author":"Jia","year":"2012","journal-title":"Semin. Cancer Biol."},{"issue":"April (2)","key":"10.1016\/j.biopha.2018.08.146_bib0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.semcancer.2012.01.007","article-title":"Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000\u20132011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors","volume":"22","author":"Hildesheim","year":"2012","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.biopha.2018.08.146_bib0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1515\/med-2017-0025","article-title":"Role of Epstein-Barr virus in the development of nasopharyngeal carcinoma","volume":"12","author":"Zhang","year":"2017","journal-title":"Open Med."},{"issue":"2","key":"10.1016\/j.biopha.2018.08.146_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2012.01.007","article-title":"Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000\u20132011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors","volume":"22","author":"Hildesheim","year":"2012","journal-title":"Semin. Cancer Biol."},{"issue":"July (3)","key":"10.1016\/j.biopha.2018.08.146_bib0035","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.semradonc.2012.03.008","article-title":"Current management of nasopharyngeal cancer","volume":"22","author":"Lee","year":"2012","journal-title":"Semin. Radiat. Oncol."},{"issue":"January (1)","key":"10.1016\/j.biopha.2018.08.146_bib0040","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00432-013-1542-x","article-title":"Prognostic value of tumor volume for patients with nasopharyngeal carcinoma treated with concurrent chemotherapy and intensity-modulated radiotherapy","volume":"140","author":"Wu","year":"2014","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"April (2)","key":"10.1016\/j.biopha.2018.08.146_bib0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.anl.2011.02.012","article-title":"Current understanding and management of nasopharyngeal carcinoma","volume":"39","author":"Yoshizaki","year":"2012","journal-title":"Auris Nasus Larynx"},{"issue":"June (6)","key":"10.1016\/j.biopha.2018.08.146_bib0050","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1470-2045(15)70126-9","article-title":"Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis","volume":"16","author":"Blanchard","year":"2015","journal-title":"Lancet Oncol."},{"issue":"March (3)","key":"10.1016\/j.biopha.2018.08.146_bib0055","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.radonc.2014.02.003","article-title":"Evolution of treatment for nasopharyngeal cancer\u2014success and setback in the intensity-modulated radiotherapy era","volume":"110","author":"Lee","year":"2014","journal-title":"Radiother. Oncol."},{"issue":"February (1)","key":"10.1016\/j.biopha.2018.08.146_bib0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.canlet.2012.10.033","article-title":"MicroRNA-29c enhances the sensitivities of human nasopharyngeal carcinoma to cisplatin-based chemotherapy and radiotherapy","volume":"329","author":"Zhang","year":"2013","journal-title":"Cancer Lett."},{"issue":"March (2)","key":"10.1016\/j.biopha.2018.08.146_bib0065","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.canlet.2013.11.006","article-title":"Cancer stem-like cell characteristics induced by EB virus-encoded LMP1 contribute to radioresistance in nasopharyngeal carcinoma by suppressing the p53-mediated apoptosis pathway","volume":"344","author":"Yang","year":"2014","journal-title":"Cancer Lett."},{"issue":"March (6)","key":"10.1016\/j.biopha.2018.08.146_bib0070","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.cell.2012.02.005","article-title":"MicroRNAs in stress signaling and human disease","volume":"148","author":"Mendell","year":"2012","journal-title":"Cell"},{"issue":"May (10)","key":"10.1016\/j.biopha.2018.08.146_bib0075","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1128\/JVI.03639-14","article-title":"Profiling of virus-encoded MicroRNAs in Epstein-Barr virus-associated gastric carcinoma and their roles in gastric carcinogenesis","volume":"89","author":"Shinozaki-Ushiku","year":"2015","journal-title":"J. Virol."},{"issue":"June (3)","key":"10.1016\/j.biopha.2018.08.146_bib0080","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/08830185.2012.748053","article-title":"Epstein-Barr virus (EBV) microRNAs: involvement in cancer pathogenesis and immunopathology","volume":"32","author":"Lopes","year":"2013","journal-title":"Int. Rev. Immunol."},{"issue":"December (39)","key":"10.1016\/j.biopha.2018.08.146_bib0085","doi-asserted-by":"crossref","first-page":"41766","DOI":"10.18632\/oncotarget.6155","article-title":"EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC","volume":"6","author":"Yan","year":"2015","journal-title":"Oncotarget"},{"issue":"April (4)","key":"10.1016\/j.biopha.2018.08.146_bib0090","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.ajpath.2013.12.024","article-title":"EBV-encoded miR-BART20-5p and miR-BART8 inhibit the IFN-gamma-STAT1 pathway associated with disease progression in nasal NK-cell lymphoma","volume":"184","author":"Huang","year":"2014","journal-title":"Am. J. Pathol."},{"issue":"September (18)","key":"10.1016\/j.biopha.2018.08.146_bib0095","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1002\/cncr.26514","article-title":"Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs","volume":"118","author":"Gourzones","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2018.08.146_bib0100","series-title":"Virology","first-page":"2655","article-title":"Epstein-Barr virus","author":"Rickinson","year":"2007"},{"key":"10.1016\/j.biopha.2018.08.146_bib0105","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.3389\/fmicb.2016.01602","article-title":"Epstein-Barr virus: diseases linked to infection and transformation","volume":"7","author":"Jha","year":"2016","journal-title":"Front. Microbiol."},{"issue":"10","key":"10.1016\/j.biopha.2018.08.146_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003685","article-title":"The cycle of EBV infection explains persistence, the sizes of the infected cell populations and which come under CTL regulation","volume":"9","author":"Hawkins","year":"2013","journal-title":"PLoS Pathog."},{"issue":"April (2)","key":"10.1016\/j.biopha.2018.08.146_bib0115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semcancer.2012.02.004","article-title":"The biology of EBV infection in human epithelial cells","volume":"22","author":"Tsao","year":"2012","journal-title":"Semin. Cancer Biol."},{"issue":"December (12)","key":"10.1016\/j.biopha.2018.08.146_bib0120","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.3390\/v4123420","article-title":"Epstein-Barr Virus (EBV)-associated gastric carcinoma","volume":"4","author":"Iizasa","year":"2012","journal-title":"Viruses"},{"issue":"June (3)","key":"10.1016\/j.biopha.2018.08.146_bib0125","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.coviro.2013.04.005","article-title":"The pathogenesis of Epstein-Barr virus persistent infection","volume":"3","author":"Thorley-Lawson","year":"2013","journal-title":"Curr. Opin. Virol."},{"issue":"January (1)","key":"10.1016\/j.biopha.2018.08.146_bib0130","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/jcmm.13354","article-title":"The oncogenic role of Epstein-Barr virus-encoded microRNAs in Epstein-Barr virus-associated gastric carcinoma","volume":"22","author":"Zhang","year":"2018","journal-title":"J. Cell. Mol. Med."},{"issue":"June (6)","key":"10.1016\/j.biopha.2018.08.146_bib0135","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/labinvest.2016.33","article-title":"Gastric adenocarcinoma microRNA profiles in fixed tissue and in plasma reveal cancer-associated and Epstein-Barr virus-related expression patterns","volume":"96","author":"Treece","year":"2016","journal-title":"Lab. Invest."},{"issue":"June (1)","key":"10.1016\/j.biopha.2018.08.146_bib0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bbrc.2013.05.008","article-title":"EBV-miR-BART1 is involved in regulating metabolism-associated genes in nasopharyngeal carcinoma","volume":"436","author":"Ye","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"August (8)","key":"10.1016\/j.biopha.2018.08.146_bib0145","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1099\/jgv.0.000889","article-title":"Epstein-Barr virus biomarkers for nasopharyngeal carcinoma in non-endemic regions","volume":"98","author":"Gurtsevitch","year":"2017","journal-title":"J. Gen. Virol."},{"issue":"July (Pt. 13)","key":"10.1016\/j.biopha.2018.08.146_bib0150","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1242\/jcs.114.13.2375","article-title":"Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis","volume":"114","author":"Yamada","year":"2001","journal-title":"J. Cell Sci."},{"issue":"February (2)","key":"10.1016\/j.biopha.2018.08.146_bib0155","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/carcin\/bgs346","article-title":"MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN","volume":"34","author":"Zhang","year":"2013","journal-title":"Carcinogenesis"},{"issue":"April (17)","key":"10.1016\/j.biopha.2018.08.146_bib0160","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1038\/onc.2014.341","article-title":"EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN","volume":"34","author":"Cai","year":"2015","journal-title":"Oncogene"},{"issue":"July","key":"10.1016\/j.biopha.2018.08.146_bib0165","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1038\/ncomms8353","article-title":"Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma","volume":"6","author":"Cai","year":"2015","journal-title":"Nat. Commun."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218313404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218313404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T06:32:37Z","timestamp":1777271557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218313404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":33,"alternative-id":["S0753332218313404"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.08.146","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Downregulation of EB virus miR-BART4 inhibits proliferation and aggressiveness while promoting radiosensitivity of nasopharyngeal carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.08.146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}